Trials open to new patients.
MON - THU: 8:30 a.m. - 4:30 p.m.
FRI: 8:30 a.m. - 12:30 p.m.
Endometriosis (M18-969) - A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Combined Oral Contraceptives in Premenopausal Women with Endometriosis and Associated Moderate to Severe Pain
Cancer ALMANAC - Assessment of Multi-type Cancer Using ctDNA-02-MX-001. To collect clinical trial specimens from subjects with a positive or suspicious finding in non-invasive screening tests or confirmed diagnosis of cancer or high-risk lesions in colorectal, breast or lung cancer.
Get new treatment options while advancing research for your condition.